Infinitopes Gets Approval for Trial of Precision Cancer Vaccine
Infinitopes Ltd today announces that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Clinical Trial Application (CTA) approval for the first-in-human Phase...